A Study to Evaluate the Safety and Feasibility of Exablate Model 4000 Type-2 to temporarily mediate Blood-Brain Barrier Disruption (BBBD) in patients with suspected infiltrating glioma in the setting of planned surgical interventions

A Study to Evaluate the Safety and Feasibility of Exablate Model 4000 Type-2 to temporarily mediate Blood-Brain Barrier Disruption (BBBD) in patients with suspected infiltrating glioma in the setting of planned surgical interventions

Brief description of study

The goal of this prospective, non-randomized, single-arm study is to evaluate the safety and feasibility of using ExAblate Model 4000 Type-2 Neuro-System as a tool to disrupt the blood brain barrier in a temporary and localized fashion in patients with suspected infiltrating glioma undergoing planned surgical interventions.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    surgery
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 08 Jul 2020. Study ID: 833809

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center